Drug Type Small molecule drug |
Synonyms Amiloride/spironolactone, Spironolactone/Amiloride, Spironolactone/Amiloride-Hydrochloride + [1] |
Target |
Mechanism ENaCα inhibitors(sodium channel epithelial 1 subunit alpha inhibitors), MR antagonists(Mineralocorticoid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H32O4S |
InChIKeyLXMSZDCAJNLERA-ZHYRCANASA-N |
CAS Registry52-01-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 2 | US | - | - |
Hypertension | Phase 2 | - | - | |
Hypertension | Phase 2 | - | - |